- Home
- WIW vs ALMS Comparison
WIW vs ALMS Comparison
Compare WIW & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIW
- ALMS
- Stock Information
- Founded
- WIW 2004
- ALMS 2021
- Country
- WIW United States
- ALMS United States
- Employees
- WIW N/A
- ALMS N/A
- Industry
- WIW Finance Companies
- ALMS
- Sector
- WIW Finance
- ALMS
- Exchange
- WIW Nasdaq
- ALMS NYSE
- Market Cap
- WIW 522.5M
- ALMS 469.0M
- IPO Year
- WIW N/A
- ALMS 2024
- Fundamental
- Price
- WIW $8.55
- ALMS $7.66
- Analyst Decision
- WIW
- ALMS Strong Buy
- Analyst Count
- WIW 0
- ALMS 6
- Target Price
- WIW N/A
- ALMS $29.60
- AVG Volume (30 Days)
- WIW 229.9K
- ALMS 122.0K
- Earning Date
- WIW 01-01-0001
- ALMS 02-15-2025
- Dividend Yield
- WIW 11.14%
- ALMS N/A
- EPS Growth
- WIW N/A
- ALMS N/A
- EPS
- WIW N/A
- ALMS N/A
- Revenue
- WIW N/A
- ALMS N/A
- Revenue This Year
- WIW N/A
- ALMS N/A
- Revenue Next Year
- WIW N/A
- ALMS N/A
- P/E Ratio
- WIW N/A
- ALMS N/A
- Revenue Growth
- WIW N/A
- ALMS N/A
- 52 Week Low
- WIW $8.01
- ALMS $6.75
- 52 Week High
- WIW $9.37
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- WIW 63.98
- ALMS N/A
- Support Level
- WIW $8.23
- ALMS N/A
- Resistance Level
- WIW $8.60
- ALMS N/A
- Average True Range (ATR)
- WIW 0.06
- ALMS 0.00
- MACD
- WIW 0.04
- ALMS 0.00
- Stochastic Oscillator
- WIW 85.90
- ALMS 0.00
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.